<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A total of 1436 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> underwent resective surgery: 244 (15.6%) received combined interventions, 94 (41.9%) pelvic exenteration (PE), 38 (40.4%) complete PE, 9 (9.6%) of which were infralevator and 29 (30.8%) supralevator </plain></SENT>
<SENT sid="1" pm="."><plain>In 56 (59.6%) patients posterior PE was performed, supralevator was performed in 17 (18.1%) cases and infralevator in 39 (41.5%) cases </plain></SENT>
<SENT sid="2" pm="."><plain>In 47 (69.1%) of 68 supralevator PE recipients colonic anastomosis was formed </plain></SENT>
<SENT sid="3" pm="."><plain>In 21 (38.9%) patients a terminal colostoma was formed, in 29 (76.3%) of 38 patients incontinent urinary diversion was formed </plain></SENT>
<SENT sid="4" pm="."><plain>Continent urinary diversion was performed in 9 (23.7%) patients </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty six (27.6%) patients had 43 post-operative complications which were lethal in 7 (26.9%) cases </plain></SENT>
</text></document>